Category verbal fluency performance may be impaired in amnestic mild cognitive impairment

Márcio Luiz Figueredo Balthazar1, Fernando Cendes2, Benito Pereira Damasceno3

  • 1Postgraduate Neurologist. Department of Neurology, Medical School, State University of Campinas - SP, Brazil.

Insights

Patients with mild cognitive impairment (MCI) showed deficits in animal category verbal fluency, impacting non-memory tasks. This suggests potential working memory influences in aMCI, distinct from Alzheimer's disease progression.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) and Alzheimer's disease (AD) represent a spectrum of cognitive decline.
  • Understanding early-stage cognitive deficits is crucial for timely diagnosis and intervention.
  • Category verbal fluency (VF) is a sensitive measure of executive function and semantic processing.

Purpose of the Study:

  • To investigate category verbal fluency (VF) for animals in individuals with amnestic mild cognitive impairment (aMCI), mild Alzheimer's disease (AD), and normal controls.
  • To compare the performance of aMCI and mild AD patients on animal category VF tasks against healthy individuals.
  • To explore potential underlying factors, such as working memory, contributing to VF deficits in aMCI.

Main Methods:

  • A cohort of 15 mild AD patients, 15 aMCI patients, and 15 normal controls participated.
  • Participants underwent comprehensive neuropsychological testing, including animal category VF, lexical-semantic tasks, digit span, and memory assessments.
  • Statistical analyses included ANOVA for intergroup comparisons and Pearson's correlation for exploring relationships between cognitive functions.

Main Results:

  • Patients with aMCI demonstrated lower performance on animal category VF and backward digit span compared to controls.
  • Mild AD patients exhibited significantly poorer performance across all tested cognitive domains compared to both aMCI patients and controls.
  • aMCI patients performed better than mild AD patients on most measures, including animal category VF.

Conclusions:

  • Amnestic mild cognitive impairment (aMCI) can manifest with impaired performance on non-memory-based tasks, such as animal category verbal fluency.
  • The observed deficits in animal category VF in aMCI may be influenced by working memory limitations.
  • These findings highlight the heterogeneity of cognitive profiles within MCI and the importance of assessing diverse cognitive functions beyond episodic memory.

Related Concept Videos

Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
604
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
584
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
935
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
671